A desire to see richer shareholders, smarter management – and poorer lawyers
When politicians on Capitol Hill try to put limits on tort litigation, it's a reasonably safe assumption that lobbyists are paying them on behalf of companies seeking impunity to put asbestos in lungs, lead in children and poisons in petrol – or at least to get a free pass for doing so in the past.
But while companies should pay compensation to those who have suffered from their actions, there is one exception where the anti-tort lobbyists are halfjustified: shareholder suits.
Shareholder
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495